High-affinity Src-SH2 ligands which do not activate
Tyr(527)-phosphorylated Src in an experimental in vivo system.
Mandine E, Jean-Baptiste V, Vayssiere B, Gofflo D, Benard D, Sarubbi E, Deprez P, Baron R, Superti-Furga G, Lesuisse D
Biochem Biophys Res Commun 2002 Oct 25; 298 (2), 185-92
PMID:
12387813
Phosphotyrosine-binding domains in signal transduction.
Yaffe MB
Nat Rev Mol Cell Biol 2002 Mar; 3 (3), 177-86
PMID:
11994738
SH2 domains, interaction modules and cellular wiring.
Pawson T, Gish GD, Nash P
Trends Cell Biol 2001 Dec; 11 (12), 504-11
PMID:
11719057
'Srcasm: a novel Src activating and signaling molecule.
Seykora JT, Mei L, Dotto GP, Stein PL
J Biol Chem 2002 Jan 25; 277 (4), 2812-22
PMID:
11711534
The interaction of Src and RACK1 is enhanced by activation of protein
kinase C and tyrosine phosphorylation of RACK1.
Chang BY, Chiang M, Cartwright CA
J Biol Chem 2001 Jun 8; 276 (23), 20346-56
PMID:
11279199
c-Src tyrosine kinase binds the beta 2-adrenergic receptor via
phospho-Tyr-350, phosphorylates G-protein-linked receptor kinase 2, and
mediates agonist-induced receptor desensitization.
Fan G, Shumay E, Malbon CC, Wang H
J Biol Chem 2001 Apr 20; 276 (16), 13240-7
PMID:
11278940
The c-Src tyrosine kinase regulates signaling of the human DF3/MUC1
carcinoma-associated antigen with GSK3 beta and beta-catenin.
Li Y, Kuwahara H, Ren J, Wen G, Kufe D
J Biol Chem 2001 Mar 2; 276 (9), 6061-4
PMID:
11152665
c-Src regulates the interaction between connexin-43 and ZO-1 in cardiac
myocytes.
Toyofuku T, Akamatsu Y, Zhang H, Kuzuya T, Tada M, Hori M
J Biol Chem 2001 Jan 19; 276 (3), 1780-8
PMID:
11035005
Investigation of phosphotyrosine recognition by the SH2 domain of the Src
kinase.
Bradshaw JM, Mitaxov V, Waksman G
J Mol Biol 1999 Nov 5; 293 (4), 971-85
PMID:
10543978
C-terminal Src kinase associates with ligand-stimulated insulin-like
growth factor-I receptor.
Arbet-Engels C, Tartare-Deckert S, Eckhart W
J Biol Chem 1999 Feb 26; 274 (9), 5422-8
PMID:
10026153
RACK1, a receptor for activated C kinase and a homolog of the beta subunit
of G proteins, inhibits activity of src tyrosine kinases and growth of NIH
3T3 cells.
Chang BY, Conroy KB, Machleder EM, Cartwright CA
Mol Cell Biol 1998 Jun; 18 (6), 3245-56
PMID:
9584165
Modular peptide recognition domains in eukaryotic signaling.
Kuriyan J, Cowburn D
Annu Rev Biophys Biomol Struct 1997; 26, 259-88
PMID:
9241420
Cloning of a novel T-cell protein FYB that binds FYN and
SH2-domain-containing leukocyte protein 76 and modulates interleukin 2
production.
da Silva AJ, Li Z, de Vera C, Canto E, Findell P, Rudd CE
Proc Natl Acad Sci U S A 1997 Jul 8; 94 (14), 7493-8
PMID:
9207119
In vitro phosphorylation of the epidermal growth factor receptor
autophosphorylation domain by c-src: identification of phosphorylation
sites and c-src SH2 domain binding sites.
Lombardo CR, Consler TG, Kassel DB
Biochemistry 1995 Dec 19; 34 (50), 16456-66
PMID:
8845374
SH2 domains recognize specific phosphopeptide sequences.
Songyang Z, Shoelson SE, Chaudhuri M, Gish G, Pawson T, Haser WG, King F, Roberts T, Ratnofsky S, Lechleider RJ, et al.
Cell 1993 Mar 12; 72 (5), 767-78
PMID:
7680959
Structural basis of interactions between epidermal growth factor receptor
and SH2 domain proteins.
Sierke SL, Longo GM, Koland JG
Biochem Biophys Res Commun 1993 Feb 26; 191 (1), 45-54
PMID:
7680558
Binding of SH2 domains of phospholipase C gamma 1, GAP, and Src to
activated growth factor receptors.
Anderson D, Koch CA, Grey L, Ellis C, Moran MF, Pawson T
Science 1990 Nov 16; 250 (4983), 979-82
PMID:
2173144
Structural elements that regulate pp59c-fyn catalytic activity,
transforming potential, and ability to associate with polyomavirus
middle-T antigen.
Cheng SH, Espino PC, Marshall J, Harvey R, Merrill J, Smith AE
J Virol 1991 Jan; 65 (1), 170-9
PMID:
1985196